|
WO2020089424A1
|
|
Solid compositions of cocrystals of cannabinoids
|
|
US2020369586A1
|
|
A cocrystal of 2-[(1r,6r)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
|
|
EP3412661A1
|
|
Cocrystals of vortioxetine hydrobromide and resorcinol
|
|
CN109195954A
|
|
The chiral resolution and its eutectic of the intermediate of Wo Leisheng
|
|
EP3330260A1
|
|
Process for the preparation of an intermediate for the synthesis of i.a. carfilzomib
|
|
EP3210975A1
|
|
Cocrystals of lorcaserin
|
|
EP3184516A1
|
|
Crystalline inclusion complexes of mirabegron with beta-cyclodextrin
|
|
CN104520278A
|
|
A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside
|
|
WO2013160354A1
|
|
Crystalline forms of saxagliptin
|
|
EP2573084A1
|
|
Novel crystalline forms of rivaroxaban and processes for their preparation
|
|
EP2521723A1
|
|
Process for the preparation of rivaroxaban and intermediates thereof
|
|
WO2011098160A1
|
|
Enantiomerically enriched aminodiphosphines as ligands for the preparation of catalysts for asymmetric synthesis
|
|
EP2305646A1
|
|
A process for the preparation of trans-(2R)-4-substituted-pipecolic acids and esters thereof, and intermediate compounds used therein
|
|
WO2007071750A1
|
|
Intermediates and processes for the preparation of valsartan
|
|
ES2298067A1
|
|
BIDENTED QUIRAL LIGANDS OF TYPE P, S AND ITS USE IN THE REACTION OF PAUSON-KHAND.
|
|
KR20070100717A
|
|
Intermediate compounds for the preparation of an angiotensin ii receptor antagonist
|
|
ES2220226A1
|
|
Stereoselective method of preparing gamma-amino vinyl sulphones
|
